Literature DB >> 18442472

Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice.

Elizabeth E Girroir1, Holly E Hollingshead, Pengfei He, Bokai Zhu, Gary H Perdew, Jeffrey M Peters.   

Abstract

The expression patterns of PPARbeta/delta have been described, but the majority of these data are based on mRNA data. To date, there are no reports that have quantitatively examined the expression of PPARbeta/delta protein in mouse tissues. In the present study, a highly specific PPARbeta/delta antibody was developed, characterized, and used to examine tissue expression patterns of PPARbeta/delta. As compared to commercially available anti-PPARbeta/delta antibodies, one of six polyclonal anti-PPARbeta/delta antibodies developed was significantly more effective for immunoprecipitation of in vitro-translated PPARbeta/delta. This antibody was used for quantitative Western blot analysis using radioactive detection methods. Expression of PPARbeta/delta was highest in colon, small intestine, liver, and keratinocytes as compared to other tissues including heart, spleen, skeletal muscle, lung, brain, and thymus. Interestingly, PPARbeta/delta expression was localized in the nucleus and RXRalpha can be co-immunoprecipitated with nuclear PPARbeta/delta. Results from these studies demonstrate that PPARbeta/delta expression is highest in intestinal epithelium, liver, and keratinocytes, consistent with significant biological roles in these tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442472      PMCID: PMC2586836          DOI: 10.1016/j.bbrc.2008.04.086

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Reevaluation of the PPAR-beta/delta ligand binding domain model reveals why it exhibits the activated form.

Authors:  Stewart A Fyffe; Magnus S Alphey; Lori Buetow; Terry K Smith; Michael A J Ferguson; Morten D Sørensen; Fredrik Björkling; William N Hunter
Journal:  Mol Cell       Date:  2006-01-06       Impact factor: 17.970

2.  Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa.

Authors:  A Mansén; H Guardiola-Diaz; J Rafter; C Branting; J A Gustafsson
Journal:  Biochem Biophys Res Commun       Date:  1996-05-24       Impact factor: 3.575

3.  Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development.

Authors:  O Braissant; W Wahli
Journal:  Endocrinology       Date:  1998-06       Impact factor: 4.736

4.  Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes.

Authors:  Hong-Ping Guan; Takahiro Ishizuka; Patricia C Chui; Michael Lehrke; Mitchell A Lazar
Journal:  Genes Dev       Date:  2005-01-28       Impact factor: 11.361

5.  The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.

Authors:  Yanhong Shi; Michelle Hon; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity.

Authors:  Dae J Kim; Iain A Murray; Amanda M Burns; Frank J Gonzalez; Gary H Perdew; Jeffrey M Peters
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

Review 7.  The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation.

Authors:  Andrew D Burdick; Dae J Kim; Marjorie A Peraza; Frank J Gonzalez; Jeffrey M Peters
Journal:  Cell Signal       Date:  2005-08-16       Impact factor: 4.315

8.  PPARdelta regulates glucose metabolism and insulin sensitivity.

Authors:  Chih-Hao Lee; Peter Olson; Andrea Hevener; Isaac Mehl; Ling-Wa Chong; Jerrold M Olefsky; Frank J Gonzalez; Jungyeob Ham; Heonjoong Kang; Jeffrey M Peters; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

9.  Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.

Authors:  S A Kliewer; B M Forman; B Blumberg; E S Ong; U Borgmeyer; D J Mangelsdorf; K Umesono; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

10.  Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.

Authors:  O Braissant; F Foufelle; C Scotto; M Dauça; W Wahli
Journal:  Endocrinology       Date:  1996-01       Impact factor: 4.736

View more
  72 in total

Review 1.  The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.

Authors:  Jeffrey M Peters; Yatrik M Shah; Frank J Gonzalez
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

2.  Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis.

Authors:  Jennifer M Monk; Wooki Kim; Evelyn Callaway; Harmony F Turk; Jennifer E Foreman; Jeffrey M Peters; Weimin He; Brad Weeks; Robert C Alaniz; David N McMurray; Robert S Chapkin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-09-22       Impact factor: 4.052

3.  Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells.

Authors:  Bokai Zhu; Combiz Khozoie; Moses T Bility; Christina H Ferry; Nicholas Blazanin; Adam B Glick; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

Review 4.  Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities.

Authors:  Curtis J Omiecinski; John P Vanden Heuvel; Gary H Perdew; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2010-11-08       Impact factor: 4.849

Review 5.  Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.

Authors:  Jeffrey M Peters; Jennifer E Foreman; Frank J Gonzalez
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

6.  PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis.

Authors:  Audrey S Dickey; Dafne N Sanchez; Martin Arreola; Kunal R Sampat; Weiwei Fan; Nicolas Arbez; Sergey Akimov; Michael J Van Kanegan; Kohta Ohnishi; Stephen K Gilmore-Hall; April L Flores; Janice M Nguyen; Nicole Lomas; Cynthia L Hsu; Donald C Lo; Christopher A Ross; Eliezer Masliah; Ronald M Evans; Albert R La Spada
Journal:  Sci Transl Med       Date:  2017-12-06       Impact factor: 17.956

7.  Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines.

Authors:  Pengfei He; Michael G Borland; Bokai Zhu; Arun K Sharma; Shantu Amin; Karam El-Bayoumy; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicology       Date:  2008-10-02       Impact factor: 4.221

8.  Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.

Authors:  Pei-Li Yao; Jose L Morales; Bokai Zhu; Boo-Hyon Kang; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cancer Ther       Date:  2014-01-24       Impact factor: 6.261

9.  Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.

Authors:  Weiwei Shan; Prajakta S Palkar; Iain A Murray; Emily I McDevitt; Mary J Kennett; Boo Hyon Kang; Harriet C Isom; Gary H Perdew; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2008-07-12       Impact factor: 4.849

10.  Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor delta from Peroxisome proliferator-activated receptor gamma in the ob/ob mouse.

Authors:  Lee D Roberts; David G Hassall; Deborah A Winegar; John N Haselden; Andrew W Nicholls; Julian L Griffin
Journal:  Genome Med       Date:  2009-12-07       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.